Document is current
Any future updates will be listed below
-
Authors
Rghei, Amira D.
Yates, Jacob G. E.
Lopes, Jordyn A.
Zhan, Xuiaoyan
Guilleman, Matthew M.
Pei, Yanlong
van Lieshout, Laura P.
Santry, Lisa A.
Bridle, Byram W.
Karimi, Khalil
Thompson, Brad
Susta, Leonardo
Crowe, James E. Jr.
Wootton, Sarah K. https://orcid.org/0000-0002-5985-2406
- License Information
-
More Information
Article History
Received: 18 September 2022
Revised: 13 January 2023
Accepted: 23 January 2023
First Online: 2 February 2023
Competing interests
: LPvL and SKW are inventors on a US patent for the AAV6.2FF capsid. This patent (US20190216949) is licensed to Avamab Pharma Inc., where BT, LPvL and SKW are co-founders and BT serves as an executive. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
: This study was conducted according to the guidelines set forth by the Canadian Council on Animal Care (CCAC) and approved by the Animal Care Committee of the University of Guelph (Animal Use Protocol number 4664).
